This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Thompson, P. D. Articles by Herbert, P. N. Search for Related Content PubMed PubMed Citation Articles by Thompson, P. D. Articles by Herbert, P. N. Pubmed/NCBI databases Substance via MeSH

Circulation, Vol 84, 140-152, Copyright © 1991 by American Heart Association

ARTICLES

High density lipoprotein metabolism in endurance athletes and sedentary men

PD Thompson, EM Cullinane, SP Sady, MM Flynn, CB Chenevert and PN Herbert
Division of Preventive Cardiology, Miriam Hospital, Brown University, Providence, R.I. 02906.

BACKGROUND. Endurance athletes have higher high density lipoprotein (HDL) concentrations than sedentary controls. To examine the mechanism for this effect, we compared HDL apoprotein metabolism in 10 endurance athletes aged 34 +/- 6 years (mean +/- SD) and 10 sedentary men aged 36 +/- 8 years. METHODS AND RESULTS. Subjects were maintained on controlled diets for 4 weeks, and metabolic studies using autologously labeled 125I HDL were performed during the final 2 weeks. Lipids and lipoproteins were measured daily during these 2 weeks, and the average of 14 values was used in the analysis. HDL cholesterol (58 +/- 14 versus 41 +/- 10 mg/dl), HDL2 cholesterol (26 +/- 10 versus 12 +/- 8 mg/dl), and apolipoprotein A-I (apo A-I) (144 +/- 18 versus 115 +/- 22 mg/dl) were higher in the athletes, whereas triglyceride concentrations (60 +/- 18 versus 110 +/- 48 mg/dl) were lower (p less than 0.01 for all). Postheparin lipoprotein lipase activity was not different, but hepatic triglyceride lipase activity was 27% lower (p less than 0.06) in the athletes. The athletes' mean clearance rate of triglycerides after an infusion of Travamulsion (1 ml/kg) was nearly twofold that of the inactive men (5.8 +/- 1.5 versus 3.2 +/- 0.9%/min, p less than 0.001). There was no differences in HDL apoprotein synthetic rates, whereas the catabolic rates of both apo A-I (0.15 +/- 0.02 versus 0.22 +/- 0.05 pools per day, p less than 0.01) and apolipoprotein A-II (apo A-II) (0.15 +/- 0.02 versus 0.20 +/- 0.04 pools per day, p less than 0.05) were reduced in the trained men. Apo A-I and apo A-II half-lives correlated with HDL cholesterol in each group (r greater than 0.76, p less than 0.05 for all) but not consistently with lipase activities or fat clearance rates. This relation between apoprotein catabolism and HDL cholesterol was strongest at HDL cholesterol concentrations of less than 60 mg/dl. CONCLUSIONS. We conclude that higher HDL levels in active men are associated with increased HDL protein survival. The mechanisms mediating this effect require better definition, and other factors appear to contribute to HDL cholesterol and protein concentrations among individual subjects.

This article has been cited by other articles:

				F.-C. Riess, R. Bader, E. Cramer, L. Hansen, B. Kleijnen, G. Wahl, J. Wallrath, S. Winkel, and N. Bleese Hemodynamic Performance of the Medtronic Mosaic Porcine Bioprosthesis Up to Ten Years Ann. Thorac. Surg., April 1, 2007; 83(4): 1310 - 1318. [Abstract] [Full Text] [PDF]

				M. R. Moon, M. K. Pasque, N. A. Munfakh, S. J. Melby, J. S. Lawton, N. Moazami, J. E. Codd, T. D. Crabtree, H. B. Barner, and R. J. Damiano Jr Prosthesis-Patient Mismatch After Aortic Valve Replacement: Impact of Age and Body Size on Late Survival Ann. Thorac. Surg., February 1, 2006; 81(2): 481 - 489. [Abstract] [Full Text] [PDF]

				B. Fletcher, K. Berra, P. Ades, L. T. Braun, L. E. Burke, J. L. Durstine, J. M. Fair, G. F. Fletcher, D. Goff, L. L. Hayman, et al. Managing Abnormal Blood Lipids: A Collaborative Approach Circulation, November 15, 2005; 112(20): 3184 - 3209. [Abstract] [Full Text] [PDF]

				P. Pibarot and J. G. Dumesnil Is the hemodynamic performance of the carpentier-edwards perimount valve really equivalent to that of stentless valves? Ann. Thorac. Surg., August 1, 2003; 76(2): 656 - 657. [Full Text] [PDF]

				C. S. Morris Role of Vascular and Interventional Radiology in the Diagnosis and Management of Acute Trauma Patients J Intensive Care Med, May 1, 2002; 17(3): 112 - 126. [Abstract] [PDF]

				M. K. Banbury, D. M. Cosgrove III, J. D. Thomas, E. H. Blackstone, J. Rajeswaran, J. E. Okies, and R. M. Frater Hemodynamic stability during 17 years of the Carpentier-Edwards aortic pericardial bioprosthesis Ann. Thorac. Surg., May 1, 2002; 73(5): 1460 - 1465. [Abstract] [Full Text] [PDF]

				A. P. Goldberg, M. J. Busby-Whitehead, L. I. Katzel, R. M. Krauss, M. Lumpkin, and J. M. Hagberg Cardiovascular Fitness, Body Composition, and Lipoprotein Lipid Metabolism in Older Men J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2000; 55(6): 342M - 349. [Abstract] [Full Text]

				S. S. Khan, R. J. Siegel, M. A. DeRobertis, C. E. Blanche, R. M. Kass, W. Cheng, G. P. Fontana, and A. Trento Regression of hypertrophy after Carpentier-Edwards pericardial aortic valve replacement Ann. Thorac. Surg., February 1, 2000; 69(2): 531 - 535. [Abstract] [Full Text] [PDF]

				I. Thune, I. Njolstad, M.-L. Lochen, and O. H. Forde Physical Activity Improves the Metabolic Risk Profiles in Men and Women: The Tromso Study Arch Intern Med, August 10, 1998; 158(15): 1633 - 1640. [Abstract] [Full Text]

				M. L. McDonald, R. C. Daly, H. V. Schaff, C. J. Mullany, F. A. Miller, J. J. Morris, and T. A. Orszulak Hemodynamic Performance of Small Aortic Valve Bioprostheses: Is There a Difference? Ann. Thorac. Surg., February 1, 1997; 63(2): 362 - 366. [Abstract] [Full Text]

				R. S. Rosenson Low Levels of High-Density Lipoprotein Cholesterol (Hypoalphalipoproteinemia) An Approach to Management Arch Intern Med, July 12, 1993; 153(13): 1528 - 1538. [Abstract] [PDF]